| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/07/2008 | CN101175722A Azetidine derivatives as ccr-3 receptor antagonists |
| 05/07/2008 | CN101172973A A process for the preparation of pyridine-methylsulfinyl compounds |
| 05/07/2008 | CN100386323C Synthesis of domperidone maleate |
| 05/07/2008 | CN100386318C Tetrahydroquinoline derivatives and their use as FSH receptor modulators |
| 05/07/2008 | CN100386314C Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof |
| 05/06/2008 | US7368573 Triamide-substituted heterobicyclic compounds |
| 05/06/2008 | US7368572 Anticancer agents |
| 05/06/2008 | US7368566 Process and intermediates for preparing benzazepines |
| 05/06/2008 | US7368477 Benzofuranyl alkanamine derivatives and uses thereof |
| 05/06/2008 | US7368467 Calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 05/06/2008 | US7368465 Metalloproteinase inhibitors |
| 05/06/2008 | US7368463 Substituted 4-amino-1-benzylpiperidine compounds |
| 05/06/2008 | US7368461 Compounds and method for the treatment of overactive bladder |
| 05/06/2008 | US7368453 Quinazolinone compounds with reduced bioaccumulation |
| 05/06/2008 | US7368451 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
| 05/06/2008 | US7368450 Sodium channel blockers |
| 05/06/2008 | US7368447 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
| 05/06/2008 | US7368445 Fused pyrazole derivatives as TGF-β signal transduction inhibitors for the treatment of fibrosis and neoplasms |
| 05/06/2008 | US7368444 4-Hydroxy-1-toluenesulfonyl-2,3,4,5-tetrahydro-1H-1-benzazepine, for example; useful as the preventive and/or treatment medicine against diseases caused by stress |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/06/2008 | CA2390649C 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them |
| 05/06/2008 | CA2294352C Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6] cyclohepta[1,2-b]pyridine |
| 05/02/2008 | WO2008051873A2 Phenylurea compounds as soluble epoxide hydrolase inhibitors |
| 05/02/2008 | WO2008051597A1 Process for the preparation of imatinib |
| 05/02/2008 | WO2008051532A1 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands |
| 05/02/2008 | WO2008051047A1 Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same |
| 05/02/2008 | WO2008050732A1 Iminopyridine derivative and use thereof |
| 05/02/2008 | WO2008050162A1 Process for the preparation of desloratadine adduct formed with carbon dioxide |
| 05/02/2008 | WO2008050117A1 Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators |
| 05/02/2008 | WO2008049994A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90 |
| 05/02/2008 | WO2008049950A1 Novel polynitrogenated systems as anti-hiv agents |
| 05/02/2008 | WO2008049919A2 Rho kinase inhibitors |
| 05/02/2008 | WO2008049875A1 Novel substituted piperidyl-propane-thiols |
| 05/02/2008 | WO2008049874A1 Piperidyl-propane-thiol ccr3 modulators |
| 05/02/2008 | WO2008049806A1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| 05/02/2008 | WO2008049585A1 Pyridazine derivatives |
| 05/02/2008 | WO2008049538A1 Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors |
| 05/02/2008 | WO2008019971A3 Arylpiperazine derivatives and uses thereof |
| 05/02/2008 | WO2008011611A3 Compounds and compositions as itpkb inhibitors |
| 05/02/2008 | WO2008002676A3 Biaryl compositions and methods for modulating a kinase cascade |
| 05/02/2008 | WO2007150010A3 Cyclopropyl amine derivatives as histamin h3 receptor modulators |
| 05/02/2008 | WO2007146341A3 Amorphous and crystalline forms of pantoprazole magnesium salt |
| 05/02/2008 | CA2667551A1 Novel polynitrogenated systems as anti-hiv agents |
| 05/02/2008 | CA2667548A1 Substituted piperidyl-propane-thiols |
| 05/02/2008 | CA2667547A1 Piperidyl-propane-thiol ccr3 modulators |
| 05/02/2008 | CA2667435A1 Chemical compounds |
| 05/02/2008 | CA2667316A1 Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators |
| 05/02/2008 | CA2667235A1 Pyridazine derivatives |
| 05/02/2008 | CA2667007A1 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydrocyclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands |
| 05/02/2008 | CA2666482A1 Soluble epoxide hydrolase inhibitors |
| 05/02/2008 | CA2664141A1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| 05/02/2008 | CA2664115A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90 |
| 05/01/2008 | US20080103311 Retroviral protease inhibitors |
| 05/01/2008 | US20080103306 preparation of an imidazole derivative of formula I,** Image-1wherein R1, R2, R3 and R4 are described hereinabove. These compounds can be used in the treatment or prevention of mGluR5 receptor mediated disorders. and treatment of pain, psychosis and memory deficits |
| 05/01/2008 | US20080103183 New imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors |
| 05/01/2008 | US20080103182 N-[1-(4-Difluoromethoxy-benzyl)-1H-indazol-3-yl]-terephthalamic acid;liver carnitine palmitoyl transferase 1 (L-CPT1) nhibitor; antidiabetic and hypotensive agent; obesity, insulin resistance, hyperglycemia; reduce liver beta -oxidation, consequently inhibit gluconeogenesis |
| 05/01/2008 | US20080103177 New use of iloperidone |
| 05/01/2008 | US20080103174 Ether derivatives |
| 05/01/2008 | US20080103173 Compounds Having Activity At Nk3 Receptor And Uses Thereof In Medicine |
| 05/01/2008 | US20080103172 as tyrosine, serine/threonine, cyclin-dependent kinases, HER protein; 5-{2-[3-[4-trifluoromethyl-1-(2-trimethylsilanyl-ethoxymethyl)-1H-imidazol-2-yl]-1-(2-trimethylsilanyl-ethoxymethyl)-1H-pyrazol-4-yl]-vinyl}-pyridine-3-carbaldehyde; antiproliferative, antiinflammatory agent, neurodegenerative diseases |
| 05/01/2008 | US20080103163 Nociceptine antagonists; hydrochloride salts of N-amidino-2-{[2-(4-chlorobenzoylamino)-6-methylquinazolin-4-yl]amino}cyclohexylamine, 1-[1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one and N-(4-amino-2-methyl-6-quinolyl)-2-[(4-ethylphenoxy)methyl]benzamide |
| 05/01/2008 | US20080103162 Antipruritics |
| 05/01/2008 | US20080103161 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
| 05/01/2008 | US20080103154 3, 4-dihydro-2(IH)-quinolinone and 2(1H)-quinolinone derivatives |
| 05/01/2008 | US20080103150 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level |
| 05/01/2008 | US20080103148 Preventing ventilator induced pneumonia; utilizing compounds having longer half life on mucosal surfaces |
| 05/01/2008 | US20080103139 3-Carbamoyl-2-Pyridone Derivative |
| 05/01/2008 | US20080103136 3-[1-(2-chlorophenyl)ethoxy]-5-imidazo[1,2-a]pyridin-3-ylthiophene-2-carboxyamide; polo like kinase inhibitor; antitumor and anticarcinogenic agent; mitotic phase (M phase) of the cell cycle |
| 05/01/2008 | US20080103135 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine |
| 05/01/2008 | US20080102031 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction |
| 05/01/2008 | US20080101989 Methods, Compositions and Kits Pertaining to Analyte Determination |
| 05/01/2008 | US20080100208 Organic light-emitting compound, organic light-emitting device including the compound, and method of manufacturing the organic light-emitting device |
| 04/30/2008 | EP1916245A1 Indole derivative having pgd2 receptor antagonist activity |
| 04/30/2008 | EP1916240A1 Pyridazine derivatives |
| 04/30/2008 | EP1916239A1 Pyridone compound |
| 04/30/2008 | EP1915365A2 Carboxamide compound and use of the same |
| 04/30/2008 | EP1915364A1 Pyrazole derivatives as therapeutic agents |
| 04/30/2008 | EP1915363A1 Oxopyridyl quinoline amides as nk3 receptor modulators |
| 04/30/2008 | EP1915362A1 Amide alkyl pyridiyl quinolines as nk3 receptor modulators |
| 04/30/2008 | EP1915361A1 Alkylpyridyl quinolines as nk3 receptor modulators |
| 04/30/2008 | EP1915351A1 Quinazoline derivatives useful in cancer treatment |
| 04/30/2008 | EP1915350A1 Amide derivatives |
| 04/30/2008 | EP1915348A1 Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 04/30/2008 | EP1915345A1 Fluoro substituted 2-oxo azepan derivatives |
| 04/30/2008 | EP1716118B1 Tetrahydrobenzo[d]azepin-2- one derivatives and the use thereof for treating cardiovascular diseases |
| 04/30/2008 | EP1713791B1 5-fluoro- and chloro-pyridin-2-yl-tetrazoles as ligands of the metabotropic glutamate receptor-5 |
| 04/30/2008 | EP1601664B1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
| 04/30/2008 | DE102006050516A1 New pyrazol-3-one compounds are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful e.g. to treat and/or prophylaxis heart-circulation diseases, heart failure, anemia, chronic kidney diseases and renal failure |
| 04/30/2008 | DE102006050515A1 New substituted dipyridiyl-dihydropyrazolone derivatives are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat/prevent e.g. cardiovascular diseases, heart-circulation diseases, heart failure and anemia |
| 04/30/2008 | DE102006050513A1 New substituted dihydropyrazolone derivatives are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat/prevent e.g. cardiovascular diseases, heart-circulation diseases, heart failure and anemia |
| 04/30/2008 | DE102006050512A1 New substituted dihydropyrazole- and dihydrotriazole derivatives are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat/prevent e.g. cardiovascular diseases, heart-circulation diseases and anemia |
| 04/30/2008 | DE102006050511A1 New substituted dihydrotriazolone compounds are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat or prophylaxis e.g. heart insufficiency, anemia, chronic kidney diseases and renal failure |
| 04/30/2008 | DE102006050510A1 New substituted dihydropyrazolthione compounds are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat or prevent e.g. heart insufficiency, anemia, chronic kidney diseases and renal failure |
| 04/30/2008 | CN101171249A Method for producing indole derivative having piperidine ring |
| 04/30/2008 | CN101171248A 3-mono- and 3,5-disubstituted piperidine derivatives as renin inhibitors |
| 04/30/2008 | CN101171247A Pyrrole derivatives as DNA gyrase and topoisomerase inhibitors |
| 04/30/2008 | CN101171245A Indolylamino quinazoline derivatives as antitumor agents |
| 04/30/2008 | CN101171244A Indazolylamino quinazoline derivatives as antitumor agents |
| 04/30/2008 | CN101171008A Proton pump inhibitors in the treatment of sleep disturbance due to silent gastro-esophageal reflux |
| 04/30/2008 | CN101168541A Quinolone carboxylic acid derivatives, preparation method and medical use thereof |